News
Xanadu Licences Intranasal Vaccine Booster To Stop Virus
Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position itself to give its...
News
Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics
Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities through the acquisition of...
IT & Data Management
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech industry –...
Drug Research
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
Northwest Biotherapeutic, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced commencement of production of its first dendritic cell cancer...
News
Moderna And Rovi Extend Mrna Manufacturing Collaboration
A contract extension has been put in place between Moderna, Inc. and Spain’s Rovi, which shall cover the production of formers vaccine doses, including...
News
World’s First Monoclonal Antibody Prequalifies To Treat COVID
In order to increase access to treatments that are recommended to fight COVID-19, the WHO has added a monoclonal antibody treatment called Tocilizumab to...
Press Releases
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global, multi-year definitive licensing agreement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read